# Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer

> **NCT07489729** · NA · COMPLETED · sponsor: **Tanta University** · enrollment: 60 (actual)

## Conditions studied

- Hypofractionated Dose
- Prostate Cancer Patients

## Interventions

- **RADIATION:** Hypofractionated Intensity-Modulated Radiation Therapy
- **RADIATION:** Conventional Intensity-Modulated Radiation Therapy

## Key facts

- **NCT ID:** NCT07489729
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-30
- **Primary completion:** 2024-06-30
- **Final completion:** 2024-06-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07489729

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07489729, "Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07489729. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*